In the BioHarmony Drug Report Database

"Preview" Icon

Prasterone

Intrarosa (prasterone) is a small molecule pharmaceutical. Prasterone was first approved as Intrarosa on 2016-11-16. It is used to treat adrenal insufficiency, dyspareunia, lupus vulgaris, and sexual and gender disorders in the USA. It has been approved in Europe to treat postmenopause. It is known to target glycine receptor subunit alpha-1, glycine receptor subunit alpha-2, glycine receptor subunit alpha-3, and glycine receptor subunit beta. Intrarosa’s patents are valid until 2031-03-19 (FDA).

 

Trade Name

 

Intrarosa
 

Common Name

 

prasterone
 

ChEMBL ID

 

CHEMBL90593
 

Indication

 

adrenal insufficiency, dyspareunia, lupus vulgaris, postmenopause, sexual and gender disorders
 

Drug Class

 

Steroids (androgens, anabolics)

Image (chem structure or protein)

Prasterone structure rendering